The market is there if they can get their act together:
https://kidney.org.au/nofilter/deloittereport?utm_source=newsletter&utm_medium=email+&utm_campaign=deloitte&_cldee=GvvQgnWdIAeRcZEaXJPHSK1Z6PoaDSXqoRFS8SklzVfnYz_lYDSsOCeLE6kH3xP0&recipientid=contact-be4d77e92348ec118c62002248159d41-bba68da9badb44a1a23f418dc71ea76d&esid=fabcb715-bbb0-ed11-83fe-00224818af37
The Report mentioned is by Deloitte.
I did have concern about the size of their target market quoted in their presentations as not all diabetics have kidney problems. But the test would be good for some as a diagnosis every few years. Once diagnised you would not complete another test. You would simply be tested on your GFR blood test to tell your kidney function.
- Forums
- ASX - By Stock
- Ann: PromarkerD application for Australian MBS to be resubmitted
PIQ
proteomics international laboratories ltd
Add to My Watchlist
2.67%
!
36.5¢

The market is there if they can get their act...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $59.68M |
Open | High | Low | Value | Volume |
37.5¢ | 37.5¢ | 36.0¢ | $41.74K | 113.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17814 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 95239 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17814 | 0.365 |
9 | 99975 | 0.360 |
1 | 81739 | 0.355 |
6 | 80549 | 0.350 |
1 | 2000 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 95239 | 2 |
0.375 | 2498 | 1 |
0.380 | 20000 | 1 |
0.385 | 19500 | 1 |
0.395 | 45000 | 1 |
Last trade - 15.57pm 18/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online